Genetic and Early Environmental Influences on the Serotonin System: Consequences for Brain Development and Risk for Psychopathology
Overview
Affiliations
Background: Despite more than 60 years of research in the role of serotonin (5-HT) in psychopathology, many questions still remain. From a developmental perspective, studies have provided more insight into how 5-HT dysfunctions acquired in utero or early in life may modulate brain development. This paper discusses the relevance of the developmental role of 5-HT for the understanding of psychopathology. We review developmental milestones of the 5-HT system, how genetic and environmental 5-HT disturbances could affect brain development and the potential role of DNA methylation in 5-HT genes for brain development.
Methods: Studies were identified using common databases (e.g., PubMed, Google Scholar) and reference lists.
Results: Despite the widely supported view that the 5-HT system matures in early life, different 5-HT receptors, proteins and enzymes have different developmental patterns, and development is brain region-specific. A disruption in 5-HT homeostasis during development may lead to structural and functional changes in brain circuits that modulate emotional stress responses, including subcortical limbic and (pre)frontal areas. This may result in a predisposition to psychopathology. DNA methylation might be one of the underlying physiologic mechanisms.
Limitations: There is a need for prospective studies. The impact of stressors during adolescence on the 5-HT system is understudied. Questions regarding efficacy of drugs acting on 5-HT still remain.
Conclusion: A multidisciplinary and longitudinal approach in designing studies on the role of 5-HT in psychopathology might help to bring us closer to the understanding of the role of 5-HT in psychopathology.
Romero Garavito A, Diaz Martinez V, Juarez Cortes E, Negrete Diaz J, Montilla Rodriguez L Front Neurol. 2025; 15:1505879.
PMID: 39935805 PMC: 11810746. DOI: 10.3389/fneur.2024.1505879.
Brain serotonin, oxytocin, and their interaction: Relevance for eating disorders.
Ismaylova E, Nemoda Z, Booij L J Psychopharmacol. 2025; 39(3):187-200.
PMID: 39745000 PMC: 11843796. DOI: 10.1177/02698811241309617.
Adipokines measured during pregnancy and at birth are associated with infant negative affect.
Sullivan E, Molloy K, Dunn G, Balanzar A, Young A, Loftis J Brain Behav Immun. 2024; 120:34-43.
PMID: 38772428 PMC: 11401062. DOI: 10.1016/j.bbi.2024.05.018.
Piras G, Cadoni C, Caria F, Pintori N, Spano E, Vanejevs M Int J Neuropsychopharmacol. 2024; 27(5).
PMID: 38546531 PMC: 11120233. DOI: 10.1093/ijnp/pyae016.
Gracan R, Blazevic S, Brizic M, Hranilovic D Biomedicines. 2024; 12(2).
PMID: 38397959 PMC: 10887406. DOI: 10.3390/biomedicines12020357.